Fig. 5.
Percentage of patients reporting no LISR symptoms 5 min and 24 h after injection of 20 mg/0.5 mL GA or 20 mg/1.0 mL GA on days 0–3, days 4–6, days 7–9, and days >9
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.